What is the Historical Analysis of the Sterile Compounding Pharmacies Market Size?
The sterile compounding pharmacies market has seen considerable growth due to a variety of factors.
•The market size for sterile compounding pharmacies has seen substantial growth in the recent past. The market value is expected to increase from $5.34 billion in 2024 to $5.63 billion in 2025, showcasing a compound annual growth rate (CAGR) of 5.5%.
Factors contributing to this growth during the historic period include concerns about patient safety, a move towards personalized medicine, the introduction of home infusion therapies, clinical trials, investigational drugs, and backing for rare disease treatments.
What is the Forecasted Growth of the Sterile Compounding Pharmacies Market Size?
The sterile compounding pharmacies market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for robust expansion in the sterile compounding pharmacies market in the forthcoming years, with predictions indicating a surge to $7.3 billion by 2029. This equates to a compound annual growth rate (CAGR) of 6.7%.
Factors contributing to this projected growth during the forecast period include an increase in chronic illnesses, an aging demographic with health concerns, disruptions in drug supply and shortages, developments in precision medicine, and a heightened emphasis on patient-focused care. Key trends to watch out for during the forecast period encompass the integration of robotics and automation, stringent adherence to regulatory norms, personalized medicine and specialized compounds, a shift towards outsourced compounding services, and technological breakthroughs in aseptic procedures.
What Key Factors and Trends are Driving the Growth of the Sterile Compounding Pharmacies Market?
The rise in the demand for personalized medicine is projected to bolster the growth of the sterile compounding pharmacies market. Personalized medicine, which uses an individual's genetic or protein information to prevent, diagnose, or treat diseases, is reliant on the services of sterile compounding pharmacies. These pharmacies are instrumental in providing personalized drugs in a sterile environment, aligning the medication to the specific needs of the patient, and minimizing the potential for intolerance to certain dosages or drug compounds. This results in enhanced treatment outcomes and boosts patient satisfaction and compliance with the treatment protocol. For example, a report released in 2022 by the Personalized Medicine Coalition, a US-based personalized medicine services firm, disclosed that personalized medicines now constitute at least a quarter of new medication approvals. Backing this up was the approval of 12 new personalized medicines in 2022, marking a significant increase. Hence, the growing demand for personalized medicine is propelling the growth of the sterile compounding pharmacies market.
What are the Market Segments in the Sterile Compounding Pharmacies Market?
The sterile compounding pharmacies market covered in this report is segmented –
1) By Product: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route Of Administrations: Intravenous, Intramuscular, Subcutaneous
4) By End-Users: Adults, Pediatrics, Geriatrics, Veterinary
Subsegments:
1) By Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders For Reconstitution
2) By Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
3) By Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
4) By Otic: Otic Solutions, Otic Suspensions, Otic Gels
Pre-Book The Sterile Compounding Pharmacies Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends are Shaping the Sterile Compounding Pharmacies Market?
One predominant trend emerging in the sterile compounding pharmacies market revolves around the adoption of robotic automation. Numerous leading corporations in this market are leveraging robotic automation to fortify their market presence. For example, in March 2023, Omnicell Inc., a healthcare technology firm based in the United States, unveiled the IVX Station, a revolutionary robotic compounding technology aimed at ensuring safer and more efficient sterile compounding preparations through automation. The IVX Station boasts an automatic compounding procedure in an ISO Class 5 setting, along with ongoing monitoring of temperature, humidity, and particles. It was designed with an emphasis on safety, incorporating advanced vision systems, gravimetric verification, automated labelling, and automated application of tamper-proof syringe caps. Moreover, this cutting-edge technology offers scalability with a cloud-based formulation library that constantly updates, ensuring manufacturers have access to the latest approved formulations.
Who Are the Key Players in the Sterile Compounding Pharmacies Market?
Major companies operating in the sterile compounding pharmacies market include:
• B. Braun SE
• PharMerica Corporation
• Fagron Group BV
• QuVa Pharma Inc.
• NewCo Pharma GmbH
• Medisca
• PharMEDium Healthcare Holdings Inc.
• Central Admixture Pharmacy Services (CAPS)
• SandsRx LLC
• LeeSar Inc.
• Avella Specialty Pharmacy
• Stokes Pharmacy Inc.
• Imprimis Pharmaceuticals Inc.
• Wells Pharmacy Network LLC
• McGuff Compounding Pharmacy Services Inc.
• Potter's House Apothecary Inc.
• Pharos Innovations LLC
• Triangle Compounding Pharmacy Inc.
• Valor Compounding Pharmacy Inc.
• Pace Pharmacy
• PenCol Specialty Pharmacy LLC
• Pavilion Compounding Pharmacy LLC
• Olympia Pharmacy
• MedisourceRx
• Stat RX Pharmacy
• Rx3 Compounding Pharmacy
• Atlas Pharmaceuticals Co. Ltd.
• ReNue Rx
• Premier Pharmacy Labs Inc.
• Absolute Pharmacy Inc.
What are the Regional Insights into the Sterile Compounding Pharmacies Market?
North America was the dominant region in the sterile compounding pharmacies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sterile compounding pharmacies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
